Abstract
TIRC7 is a cell surface molecule which is expressed in T and B lymphocytes and negatively regulates their function. Anti-TIRC7 specific monoclonal antibody (mAb) inhibited T cell memory response to recall antigens. Up-regulation of TIRC7 on lymphocytes from joint tissue of patients with Rheumatoid Arthritis (RA) and mice with collagen induced arthritis (CIA) suggested TIRC7 as a novel target to promote anti-inflammatory reaction. Anti-TIRC7 mAb administration significantly inhibited the induction and progression of CIA and the anti-collagen IgG1 and IgG2a antibody response. Combination therapy of anti-TIRC7 mAb and soluble TNF-alpha receptor demonstrated an increased inhibitory effect over the single compounds on CIA. The results demonstrate the therapeutic potential of TIRC7 targeting with mAb in diseases associated with exaggerated T and B cell responses.
Original language | English |
---|---|
Pages (from-to) | 142-51 |
Number of pages | 10 |
Journal | Clinical and Experimental Immunology |
Volume | 144 |
Issue number | 1 |
DOIs | |
Publication status | Published - Apr 2006 |
Keywords
- Animals
- Antibodies, Monoclonal
- Arthritis, Experimental
- Arthritis, Rheumatoid
- B-Lymphocytes
- Female
- Humans
- Immunoglobulin G
- Immunologic Memory
- Immunotherapy
- Knee Joint
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred DBA
- Receptors, Tumor Necrosis Factor
- Synovial Fluid
- T-Lymphocytes
- Tumor Necrosis Factor-alpha
- Up-Regulation
- Vacuolar Proton-Translocating ATPases